News Center

Home page

Peak Report

News reports

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

Release time:

2020-07-31

News from our newspaper 1# April 19 , the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical". On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital.

Shanghai North Carolina is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include antitumor drug intermediates such as tinib, alkaloids, sugars, etc. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates.

Shanghai North Carolina has two wholly-owned subsidiaries: Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide production enterprise designated by the Ministry of Industry and Information Technology. It was established in 2007 , July 20. It now has three chemical synthesis workshops and one pesticide formulation workshop, with 10 product approval documents and 13 patents. Anhui North Carolina was established in 2016 12 . Its business scope includes customization, production and sales of chemical bulk drugs and pharmaceutical intermediates, wholesale and retail of chemical raw materials and products (except hazardous chemicals), etc. It has also been approved to undertake the "Small Molecule Targeted Drug Manufacturing Base", a major emerging industry project in Anhui Province ". After the cooperation is reached, Changtai Chemical will further extend to the direction of pharmaceutical intermediates on the basis of its existing business. Anhui North Carolina will be built into a production base based on pharmaceutical raw materials to undertake the transformation of Shanghai North Carolina's achievements.

This cooperation is an important measure to strengthen the development of the pharmaceutical business sector according to the company's strategic policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development". If the cooperation can be successfully completed, Shanghai Beika and its subsidiaries will become the holding subsidiaries of Jianfeng Pharmaceutical. Spike Pharmaceuticals will use Shanghai Beika and its subsidiaries as a platform to establish a research and development and production base for APIs and intermediates, further extend and improve the industrial chain, increase the scale of the industry, improve research and development capabilities, and provide a reliable guarantee for the production of APIs for Spike Pharmaceuticals, thereby enhancing the comprehensive strength of Spike Pharmaceuticals. (Zhou Hengbin)

More information

2022 China's Top 100 Building Materials Enterprises 2022 China's Top 100 Cement Clinker Production Capacity Peak even on two authoritative lists

In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)

2023

03-21

Company sends off retired employees

On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.

2023

03-04

On the first day of the new year, group leaders went to the grassroots level.

On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.

2023

02-17

Group Companies Commend 2022 Advanced

On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.

2023

01-29

Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce

On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.

2023

01-12

Peak Pharmaceutical Donates Epidemic Prevention Materials

Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.

2023

01-12

< 1 2 3 4...61 > 跳转到页